Study of CYC202 (R-roscovitine) as an inhibitor of the cell cycle of normal and transformed epidermal keratinocytes

Project: PHD

Project Details


The study of this cell cycle inhibitor is intended to determine its interest in the treatment of epidermal cells (for instance in psoriasis). Its efficacy is tested together with its toxicity and its ability to induce differentiation.
Effective start/end date1/03/0331/12/05


  • keratinocytes
  • epidermis
  • differentiation
  • cell cycle


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.